Sun Pharma settles patent litigation with Celgene Corporation for cancer drug Revlimid

Drug major Sun Pharma has reached an agreement with Celgene Corporation, to resolve the patent litigation regarding generic version of Revlimid (lenalidomide capsules) in the US. Revlimid is used in the treatment of cancer.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3xLJqbD
via IFTTT